Dynacure

📍 Illkirch-Graffenstaden, France👥 22 employees💰 Last funded Oct 2017
Biotechnology🌐 dynacure.com
Website LinkedIn
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases. The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders. The company maintains its headquarters in Strasbourg, France.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Dynacure?
Dynacure has 2 investors on record on gritt.io.
When did Dynacure last raise funding?
The most recent investment in Dynacure recorded on gritt.io was in October 2017.
What industry is Dynacure in?
Dynacure operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Dynacure based?
Dynacure is headquartered in Illkirch-Graffenstaden, France.